Skip to main content

Table 9 Microbiological testing

From: Extracorporeal membrane oxygenation support for SARS-CoV-2: a multi-centered, prospective, observational study in critically ill 92 patients in Saudi Arabia

Cultures taken from patients on hospital admission till extubation and/or ICU discharge

 

1st collection

2nd collection

3rd collection

4th collection

5th collection

6th collection

Non-ECMO

ECMO

Non-ECMO

ECMO

Non-ECMO

ECMO

Non-ECMO

ECMO

Non-ECMO

ECMO

Non-ECMO

ECMO

Biospecimen type

 Blood

735 (52.9)

52 (56.5)

388 (27.9)

42 (45.7)

233 (16.8)

17 (18.5)

166 (12)

15 (16.3)

95 (6.8)

9 (9.8)

60 (4.3)

6 (6.5)

 Respiratory culture or tracheal aspirate

87 (6.3)

24 (26.1)

115 (8.3)

10 (10.9)

137 (9.9)

12 (13)

83 (6)

10 (10.9)

53 (3.8)

8 (8.7)

32 (2.3)

3 (3.3)

 Sputum

118 (8.5)

6 (6.5)

82 (5.9)

15 (16.3)

76 (5.5)

20 (21.7)

28 (2)

10 (10.9)

13 (0.9)

8 (8.7)

6 (0.4)

5 (5.4)

 Urine

222 (16)

7 (7.6)

387 (27.9)

17 (18.5)

210 (15.1)

11 (12)

83 (6)

13 (14.1)

34 (2.4)

10 (10.9)

34 (2.4)

9 (9.8)

 Bronchoalveolar lavage

4 (0.3)

1 (1.1)

3 (0.2)

2 (2.2)

4 (0.3)

2 (2.2)

3 (0.2)

1 (1.1)

0

0

0

0

Result

 Negative

958 (69)

39 (42.4)

781 (56.2)

34 (37)

459 (33)

25 (27.2)

223 (16.1)

18 (19.6)

122 (8.8)

11 (12)

72 (5.2)

13 (14.1)

 Positive

202 (14.5)

53 (57.6)

185 (13.3)

52 (56.5)

196 (14.1)

39 (42.4)

140 (10.1)

31 (33.7)

74 (5.3)

24 (26.1)

60 (4.3)

10 (10.9)

 Pathogen detected (if positive)

Gram-positive bacteria (no specific resistance pattern)

41 (3)

4 (4.3)

22 (1.6)

2 (2.2)

15 (1.1)

2 (2.2)

18 (1.3)

2 (2.2)

5 (0.4)

0

1 (0.1)

0

 Vancomycin resistant enterococcus (VRE)

3 (0.2)

1 (1.1)

3 (0.2)

0

2 (0.1)

1 (1.1)

3 (0.2)

0

1 (0.1)

0

1 (0.1)

0

 Methicillin-sensitive Staphylococcus aureus (MSSA)

7 (0.5)

2 (2.2)

4 (0.3)

1 (1.1)

4 (0.3)

1 (1.1)

2 (0.1)

0

1 (0.1)

0

0

0

 Methicillin-resistant Staphylococcus aureus (MRSA)

7 (0.5)

3 (3.3)

9 (0.6)

0

2 (0.1)

0

6 (0.4)

0

3 (0.2)

0

1 (0.1)

0

 Enterobacteriaceae (sensitive)

5 (0.4)

2 (2.2)

5 (0.4)

1 (1.1)

6 (0.4)

0

2 (0.1)

2 (2.2)

2 (0.1)

0

0

1 (1.1)

 Enterobacteriaceae (ESBL)

7 (0.5)

2 (2.2)

11 (0.8)

3 (3.3)

6 (0.4)

2 (2.2)

5 (0.4)

1 (1.1)

4 (0.3)

1 (1.1)

2 (0.1)

0

 Enterobacteriaceae (CRE)

6 (0.4)

6 (6.5)

3 (0.2)

4 (4.3)

7 (0.5)

6 (6.5)

6 (0.4)

2 (2.2)

7 (0.5)

5 (5.4)

5 (0.4)

0

 Enterobacteriaceae (MDR)

2 (0.1)

1 (1.1)

8 (0.6)

2 (2.2)

3 (0.2)

0

2 (0.1)

1 (1.1)

4 (0.3)

1 (1.1)

4 (0.3)

0

 Enterobacteriaceae (XDR)

0

0

1 (0.1)

0

0

0

1 (0.1)

0

1 (0.1)

0

0

0

 Pseudomonas (Sensitive)

9 (0.6)

3 (3.3)

7 (0.5)

2 (2.2)

14 (1)

0

5 (0.4)

1 (1.1)

4 (0.3)

1 (1.1)

1 (0.1)

0

 Pseudomonas (MDR)

3 (0.2)

1 (1.1)

3 (0.2)

6 (6.5)

8 (0.6)

5 (5.4)

3 (0.2)

7 (7.6)

4 (0.3)

3 (3.3)

1 (0.1)

1 (1.1)

 Pseudomonas (XDR)

0

1 (1.1)

0

1 (1.1)

0

0

2 (0.1)

0

0

0

0

0

 Acinetobacter (sensitive)

4 (0.3)

1 (1.1)

4 (0.3)

1 (1.1)

3 (0.2)

0

3 (0.2)

0

1 (0.1)

0

0

0

 Acinetobacter (MDR)

24 (1.7)

6 (6.5)

33 (2.4)

9 (9.8)

31 (2.2)

8 (8.7)

32 (2.3)

3 (3.3)

10 (0.7)

1 (1.1)

8 (0.6)

5 (5.4)

 Aspergillus

3 (0.2)

0

0

0

2 (0.1)

0

0

0

0

0

0

0

 Candida

43 (3.1)

5 (5.4)

48 (3.5)

8 (8.7)

62 (4.5)

6 (6.5)

29 (2.1)

3 (3.3)

18 (1.3)

4 (4.3)

17 (1.2)

2 (2.2)

 Other

56 (4)

26 (28.3)

45 (3.2)

18 (19.6)

51 (3.7)

15 (16.3)

38 (2.7)

12 (13)

24 (1.7)

9 (9.8)

23 (1.7)

3 (3.3)

  1. Data are presented as number (%)
  2. CRE carbapenem-resistant Enterobacteriaceae, ECMO extracorporeal membrane oxygenation, ESBL extended-spectrum b-lactamase, ICU intensive care unit, MDR multidrug-resistant, XDR extensively drug-resistant